Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05991453 · ClinicalTrials.gov registry record · NA

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

A NA study of Surgery and Pain, Postoperative, sponsored by Washington University School of Medicine.

Recruiting
Registry status
NA
Development phase
13,000
Enrollment target
20
Study locations

NCT05991453: Recruiting NA study of Surgery and Pain, Postoperative, sponsored by Washington University School of Medicine.

NCT05991453 is a NA study of Surgery and Pain, Postoperative that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 13,000 participants, below the 52,743-participant average among 120 other Surgery trials with a reported enrollment target (75% lower). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05991453, a NA study of Surgery and Pain, Postoperative, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
NA
Development phase
13,000 participants
Enrollment target
20
Study locations

Study Summary

The investigators will conduct a 13,000-patient randomized multi-center trial to determine (i) which general anesthesia technique yields superior patient recovery experiences in any of three surgical categories ((a) major inpatient surgery, (b) minor inpatient surgery, (c) outpatient surgery) and (ii) whether TIVA confers no more than a small (0.2 %) increased risk of intraoperative awareness than INVA in patients undergoing both outpatient and inpatient surgeries

Primary Outcome

The QOR15 instrument measures quality of recovery with a score of 0 - 150 points where the higher the score the better quality of recovery.

Interventions

  • OTHER Anesthetic technique Propofol TIVA
  • OTHER Anesthetic technique inhaled agent

Study Locations (20)

California

  • University of California San Francisco - San Francisco
  • Stanford University - Stanford

Massachusetts

  • Massachusetts General Hospital - Boston
  • Brigham & Women's - Boston

Michigan

  • University of Michigan - Ann Arbor
  • Henry Ford Health - Detroit

New York

  • NYU Langone - New York
  • Weill Cornell Medicine - New York

North Carolina

  • Duke University - Durham
  • Wake Forest - Winston-Salem

Arkansas

  • University of Arkansas for Medical Sciences (UAMS) - Little Rock

Connecticut

  • Yale School of Medicine - New Haven

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 13,000 participants
Start Date 2023-09-13
Est. Completion 2028-07-31
Phase NA

What NCT05991453 shows while recruiting

NCT05991453 is an interventional study that assigns participants to a tested intervention. Its 13,000 participants enrollment target places it among the larger protocols in the corpus, below the 52,743-participant average among 120 other Surgery trials with a reported enrollment target (75% lower).

The record links to 8 conditions, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which Anesthetic technique Propofol TIVA is the first listed.

NCT05991453 names 20 study sites across 15 states, led by California, Massachusetts, Michigan.

Frequently Asked Questions

What is clinical trial NCT05991453 about?

NCT05991453 is a clinical study titled "Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial". The investigators will conduct a 13,000-patient randomized multi-center trial to determine (i) which general anesthesia technique yields superior patient recovery experiences in any of three surgical categories ((a) major inpatient surgery, (b) minor inpatient surgery, (c) outpatient surgery) and (i...

What is the current status of trial NCT05991453?

This trial is currently recruiting. It is a NA study. The enrollment target is 13,000 participants. The study started on 2023-09-13. Estimated completion is 2028-07-31.

What conditions does trial NCT05991453 study?

This clinical trial studies the following conditions: Surgery, Pain, Postoperative, Quality of Life, Anesthesia, Surgery--Complications.

What interventions are being tested in trial NCT05991453?

The interventions under investigation include: Anesthetic technique Propofol TIVA (OTHER), Anesthetic technique inhaled agent (OTHER).

Who is sponsoring clinical trial NCT05991453?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05991453 being conducted?

This trial has 20 study locations across Arkansas, California, Connecticut, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05991453's enrollment target sits among peer trials

13,000 5th of 120 higher than 116 of 120 other Surgery trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07177352 · 13,000 participants · Phase 3

    Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  • NCT07028398 · 12,990 participants · NA

    CMSL Ambulatory Sensitive Condition Nudge Study 2

  • NCT03586895 · 12,838 participants · NA

    e-Connect: A Service System Intervention for Justice Youth at Risk for Suicide

  • NCT07037433 · 12,800 participants · Phase 3

    Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05991453, the US trial registry maintained by the National Library of Medicine. NCT05991453 (large enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.